Hudson Bay Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-93,600
Closed -$26.1M 1231
2025
Q2
$26.1M Sell
93,600
-431,200
-82% -$122M 0.09% 172
2025
Q1
$164M Buy
+524,800
New +$155M 0.5% 40
2019
Q1
Sell
-35,000
Closed -$6.81M 686
2018
Q4
$6.81M Sell
35,000
-5,000
-13% -$975K 0.09% 212
2018
Q3
$8.29M Sell
40,000
-21,700
-35% -$4.28M 0.1% 183
2018
Q2
$11.4M Buy
61,700
+18,000
+41% +$3.18M 0.16% 123
2018
Q1
$7.45M Buy
+43,700
New +$8.02M 0.15% 156

Other funds holding AMGN

Hudson Bay Capital Management's AMGN Position: Q3 2025 in Review

Hudson Bay Capital Management sold out of Amgen (AMGN) in Q3 2025, closing a stake of 8,561 shares — an estimated $2.39M sold.

Hudson Bay Capital Management first reported a position in AMGN in Q1 2018 and held it in 11 quarters. The position peaked at $54.6M in Q4 2022. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • Hudson Bay Capital Management reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 8,561 Amgen shares in Q3 2025, an estimated $2.39M.
  • Hudson Bay Capital Management first reported a position in Amgen in Q1 2018 and held it in 11 quarters.
  • Hudson Bay Capital Management's Amgen position peaked at $54.6M in Q4 2022.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on Hudson Bay Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.